Results 251 to 257 of about 4,564,900 (257)

The evaluation of latent tuberculosis in rheumatologic diseases for anti-TNF therapy: experience with 192 patients

Clinical Rheumatology, 2008
Sedat Kuleci, Ali Kocabaş
exaly  

Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists.

Journal of Crohn's and Colitis, 2010
Yehuda Chowers, Matthieu Allez, Maria Gazouli   +2 more
exaly  

The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease

Inflammatory Bowel Diseases, 2019
Geoffrey C Nguyen, Lisa Lix
exaly  

Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease

Expert Opinion on Biological Therapy, 2016
Lieven Pouillon, Laurent Peyrin-Biroulet, Peter Bossuyt   +2 more
exaly  

Anti-TNF therapy is not associated with an increased risk of post-colectomy complications, a population-based study

Colorectal Disease, 2018
Stephen T Ward, Felicity Evison, S Radley   +2 more
exaly  

Distinctive histopathologic phenotype in resection specimens from patients with Crohn’s disease receiving anti–TNF- therapy

Human Pathology, 2014
Richard Kirsch, Robert H Riddell, Joanna C Walsh   +2 more
exaly  

The impact of immunosuppressive therapy on QuantiFERON and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease scheduled for anti-TNF therapy

Scandinavian Journal of Gastroenterology, 2015
Konstantinos Papamichail
exaly